Targeting ribosome biogenesis in cancer: lessons learned and way forward
A Zisi, J Bartek, MS Lindström - Cancers, 2022 - mdpi.com
Simple Summary Cells need to produce ribosomes to sustain continuous proliferation and
expand in numbers, a feature that is even more prominent in uncontrollably proliferating …
expand in numbers, a feature that is even more prominent in uncontrollably proliferating …
Molecular imaging in drug development
JK Willmann, N Van Bruggen, LM Dinkelborg… - Nature reviews Drug …, 2008 - nature.com
Molecular imaging can allow the non-invasive assessment of biological and biochemical
processes in living subjects. Such technologies therefore have the potential to enhance our …
processes in living subjects. Such technologies therefore have the potential to enhance our …
Chloroquine-induced autophagic vacuole accumulation and cell death in glioma cells is p53 independent
Y Geng, L Kohli, BJ Klocke, KA Roth - Neuro-oncology, 2010 - academic.oup.com
Glioblastoma (GBM) is a high-grade central nervous system malignancy and despite
aggressive treatment strategies, GBM patients have a median survival time of just 1 year …
aggressive treatment strategies, GBM patients have a median survival time of just 1 year …
Natural and synthetic acridines/acridones as antitumor agents: their biological activities and methods of synthesis
G Cholewiński, K Dzierzbicka, AM Kołodziejczyk - Pharmacological reports, 2011 - Elsevier
Acridine derivatives constitute a class of compounds that are being intensively studied as
potential anticancer drugs. Acridines are well-known for their high cytotoxic activity; …
potential anticancer drugs. Acridines are well-known for their high cytotoxic activity; …
Double-edged swords as cancer therapeutics: simultaneously targeting p53 and NF-κB pathways
A Dey, V Tergaonkar, DP Lane - Nature reviews Drug discovery, 2008 - nature.com
The p53 and nuclear factor-κB (NF-κB) pathways play crucial roles in human cancer, in
which inactivation of p53 and hyperactivation of NF-κB is a common occurrence. Activation …
which inactivation of p53 and hyperactivation of NF-κB is a common occurrence. Activation …
Beyond DNA binding-a review of the potential mechanisms mediating quinacrine's therapeutic activities in parasitic infections, inflammation, and cancers
R Ehsanian, C Van Waes, SM Feller - Cell Communication and Signaling, 2011 - Springer
This is an in-depth review of the history of quinacrine as well as its pharmacokinetic
properties and established record of safety as an FDA-approved drug. The potential uses of …
properties and established record of safety as an FDA-approved drug. The potential uses of …
Acridine and its derivatives: a patent review (2009–2013)
B Zhang, X Li, B Li, C Gao, Y Jiang - Expert opinion on therapeutic …, 2014 - Taylor & Francis
Introduction: Acridine derivatives have been extensively explored as potential therapeutic
agents for the treatment of a number of diseases, such as cancer, Alzheimer's, and bacterial …
agents for the treatment of a number of diseases, such as cancer, Alzheimer's, and bacterial …
Targeting p53 for enhanced radio-and chemo-sensitivity
C Lu, WS El-Deiry - Apoptosis, 2009 - Springer
Abstract p53 acts as a central mediator of the cellular response to stressful stimuli. The
growth-suppressive function of p53 is lost with mutation and this occurs commonly in human …
growth-suppressive function of p53 is lost with mutation and this occurs commonly in human …
CP-31398 restores mutant p53 tumor suppressor function and inhibits UVB-induced skin carcinogenesis in mice
X Tang, Y Zhu, L Han, AL Kim… - The Journal of …, 2007 - Am Soc Clin Investig
Mutations in the tumor suppressor p53 are detectable in over 50% of all human
malignancies. Mutant p53 protein is incapable of transactivating its downstream target …
malignancies. Mutant p53 protein is incapable of transactivating its downstream target …
The functional curcumin liposomes induce apoptosis in C6 glioblastoma cells and C6 glioblastoma stem cells in vitro and in animals
Y Wang, X Ying, H Xu, H Yan, X Li… - International journal of …, 2017 - Taylor & Francis
Glioblastoma is a kind of malignant gliomas that is almost impossible to cure due to the poor
drug transportation across the blood–brain barrier and the existence of glioma stem cells …
drug transportation across the blood–brain barrier and the existence of glioma stem cells …